Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysis.
AUTOR(ES)
Moissenet, D
RESUMO
The CDC group IV c-2 bacterium is a gram-negative bacillus rarely isolated from clinical specimens. This organism caused catheter-related bacteremia in five immunocompromised children hospitalized in two distinct wards of our institution between November 1993 and October 1994. Three patients recovered on empiric antibacterial chemotherapy combining ceftazidime and amikacin, and a fourth patient required imipenem instead of ceftazidime. The fifth patient recovered without treatment. Catheter removal was never necessary. The randomly amplified polymorphic DNA technique with three different primers was applied to nine isolates recovered by culturing blood from the five children and showed that all of the patients harbored isolates of the same genotype. The source of the outbreak could not be determined.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=228993Documentos Relacionados
- Molecular Epidemiological Investigation Using a Randomly Amplified Polymorphic DNA Assay of Burkholderia cepacia Isolates from Nosocomial Outbreaks
- Characterization of Streptococcus agalactiae strains by randomly amplified polymorphic DNA analysis.
- Identification and DNA fingerprinting of Legionella strains by randomly amplified polymorphic DNA analysis.
- Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis.
- Typing of group A streptococci by random amplified polymorphic DNA analysis.
